Cinctive Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-30,893
Closed -$1.22M 471
2024
Q4
$1.22M Sell
30,893
-78,122
-72% -$2.96M 0.06% 269
2024
Q3
$3.71M Buy
109,015
+4,342
+4% +$122K 0.2% 164
2024
Q2
$2.27M Buy
+104,673
New +$2.2M 0.11% 238
2022
Q1
Sell
-23,365
Closed -$963K 669
2021
Q4
$963K Buy
+23,365
New +$1.03M 0.04% 416

Other funds holding VCYT

Cinctive Capital Management's VCYT Position: Q1 2025 in Review

Cinctive Capital Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 30,893 shares — an estimated $1.22M sold.

Cinctive Capital Management first reported a position in VCYT in Q4 2021 and held it in 4 quarters. The position peaked at $3.71M in Q3 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Cinctive Capital Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 30,893 Veracyte shares in Q1 2025, an estimated $1.22M.
  • Cinctive Capital Management first reported a position in Veracyte in Q4 2021 and held it in 4 quarters.
  • Cinctive Capital Management's Veracyte position peaked at $3.71M in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Cinctive Capital Management's 13F filing for Q1 2025, filed 15 May 2025.